Video index

1. Call to order

2. Consideration of April 22, 2022, draft meeting minutes

3. Consideration of Officer Election Procedure and Chair and Vice-Chair Elections

4. Value-Based Agreements Overview

5. Public comment on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

6. Public comment on single new drugs to be reviewed for the Medicaid PDL

7. Therapeutic and clinical drug reviews and updates: Magellan Medicaid Administration

8. Executive work session

9. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration

10. Retrospective drug utilization review (DUR): Conduent, LLC

11. Prospective prior authorization proposals (clinical edits): Kepro, LLC

12. Retrospective drug use criteria for outpatient use in Vendor Drug Program

13. Review of action items for next meeting: Oct 21, 2022, 9:00 a.m.

Jul 22, 2022 Drug Utilization Review Board (DURB) Agenda

Full agenda
Share this video

1. Call to order

2. Consideration of April 22, 2022, draft meeting minutes

3. Consideration of Officer Election Procedure and Chair and Vice-Chair Elections

4. Value-Based Agreements Overview

5. Public comment on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

6. Public comment on single new drugs to be reviewed for the Medicaid PDL

7. Therapeutic and clinical drug reviews and updates: Magellan Medicaid Administration

8. Executive work session

9. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration

10. Retrospective drug utilization review (DUR): Conduent, LLC

11. Prospective prior authorization proposals (clinical edits): Kepro, LLC

12. Retrospective drug use criteria for outpatient use in Vendor Drug Program

13. Review of action items for next meeting: Oct 21, 2022, 9:00 a.m.

© 2003-2024 Swagit Productions, LLC